| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,390 |
3,315 |
$1.09M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
639 |
602 |
$306K |
| 80053 |
Comprehensive metabolic panel |
1,910 |
1,829 |
$285K |
| 85027 |
|
1,129 |
1,097 |
$122K |
| 80061 |
Lipid panel |
1,054 |
1,036 |
$117K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
495 |
489 |
$44K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
59 |
56 |
$39K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,042 |
1,012 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,779 |
872 |
$20K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
928 |
895 |
$16K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
170 |
168 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
279 |
272 |
$10K |
| 83655 |
|
110 |
108 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
14 |
$7K |
| 87070 |
|
72 |
69 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
14 |
14 |
$7K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
14 |
14 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
97 |
93 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,335 |
1,225 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
3,753 |
3,399 |
$2K |
| 86592 |
|
14 |
14 |
$2K |
| 87340 |
|
12 |
12 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
201 |
194 |
$2K |
| 81001 |
|
459 |
427 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13 |
13 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
171 |
169 |
$1K |
| 82728 |
|
13 |
13 |
$1K |
| 81025 |
|
44 |
40 |
$300.42 |
| 87807 |
|
28 |
28 |
$145.99 |